The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials
Abstract
PURPOSE Multifraction (MF) stereotactic radiosurgery (SRS) purportedly reduces radionecrosis risk over single-fraction (SF) SRS in the treatment of large brain metastases. The purpose of the current work is to compare local control (LC) and radionecrosis rates of SF-SRS and MF-SRS in the definitive (SF-SRSD and MF-SRSD) and postoperative (SF-SRSP and MF-SRSP) settings. METHODS AND MATERIALS Population, Intervention, Control, Outcomes, Study Design/Preferred Reporting Items for Systematic Reviews and Meta-analyses and Meta-analysis of Observational Studies in Epidemiology guidelines were used to select articles in which patients had "large" brain metastases (Group A: 4-14 cm3, or about 2-3 cm in diameter; Group B: >14 cm3, or about >3 cm in diameter); 1-year LC and/or rates of radionecrosis were reported; radiosurgery was administered definitively or postoperatively. Random effects meta-analyses using fractionation scheme and size as covariates were conducted. Meta-regression and Wald-type tests were used to determine the effect of increasing tumor size and fractionation on the summary estimate, where the null hypothesis was rejected for P < .05. RESULTS Twenty-four studies were included, published between 2008 and 2017, with 1887 brain metastases. LC random effects estimate at 1 year was 77.6% for Group A/SF-SRSD and 92.9% for Group A/MF-SRSD (P = .18). LC random effects estimate at 1 year was 77.1% for Group B/SF-SRSD and 79.2% for Group B/MF-SRSD (P = .76). LC random effects estimate at 1 year was 62.4% for Group B/SF-SRSP and 85.7% for Group B/MF-SRSP (P = .13). Radionecrosis incidence random effects estimate was 23.1% for Group A/SF-SRSD and 7.3% for Group A/MF-SRSD (P = .003). Radionecrosis incidence random effects estimate was 11.7% for Group B/SF-SRSD and 6.5% for Group B/MF-SRSD (P = .29). Radionecrosis incidence random effects estimate was 7.3% for Group B/SF-SRSP and 7.5% for Group B/MF-SRSP (P = .85). Metaregression assessing 1-year LC and radionecrosis as a continuous function of increasing tumor volume was not statistically significant. CONCLUSIONS Treatment for large brain metastases with MF-SRS regimens may offer a relative reduction of radionecrosis while maintaining or improving relative rates of 1-year LC compared with SF-SRS. These findings are hypothesis-generating and require validation by ongoing and planned prospective clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
The well-built clinical question: A key to evidence-based decisions
(1995) · ACP Journal Club · doi:10.7326/acpjc-1995-123-3-a12 · Cited by 2,931
Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
The Abuse of Power: The Pervasive Fallacy of Power Calculations for Data Analysis
Hoenig, J. M., & Heisey, D. M. (2001) · The American Statistician · doi:10.1198/000313001300339897 · Cited by 2,046
Kocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.9839 · Cited by 1,671
Self-citationShaw, E., Scott, C., Souhami, L., Dinapoli, R., Kline, R., Loeffler, J., & Farnan, N. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00507-6 · Cited by 1,608
Brown, P. D., Ballman, K. V., Cerhan, J. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30441-2 · Cited by 1,220
Self-citationBrown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 958
Self-citationEvaluation of PICO as a knowledge representation for clinical questions.
Huang, X., Lin, J., & Demner‐Fushman, D. (2006) · Europe PMC (PubMed Central) · Cited by 898
The Interpretation of Random-Effects Meta-Analysis in Decision Models
Ades, A. E., Lu, G., & Higgins, J. P. T. (2005) · Medical Decision Making · doi:10.1177/0272989x05282643 · Cited by 859
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
Minniti, G., Clarke, E., Lanzetta, G., Osti, M. F., Trasimeni, G., Bozzao, A., Romano, A., & Enrici, R. M. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-48 · Cited by 828
Mahajan, A., Ahmed, S., McAleer, M. F., Weinberg, J. S., Li, J., Brown, P., Settle, S., Prabhu, S. S., Lang, F. F., Levine, N., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30414-x · Cited by 789
Self-citationThe management of brain metastases
Patchell, R. A. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00105-1 · Cited by 654
Blonigen, B. J., Steinmetz, R. D., Levin, L., Lamba, M. A., Warnick, R. E., & Breneman, J. C. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.006 · Cited by 506
Minniti, G., Scaringi, C., Paolini, S., Lanzetta, G., Romano, A., Cicone, F., Osti, M., Enrici, R. M., & Esposito, V. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.03.013 · Cited by 478
Kalkanis, S. N., Kondziolka, D., Gaspar, L. E., Burri, S. H., Asher, A. L., Cobbs, C. S., Ammirati, M., Robinson, P. D., Andrews, D. W., Loeffler, J. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0061-8 · Cited by 412
Fleiss, J. L., & Gross, A. J. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90261-7 · Cited by 404
Muacevic, A., Wowra, B., Siefert, A., Tonn, J.-C., Steiger, H.-J., & Kreth, F. W. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9510-4 · Cited by 344
Korytko, T., Radivoyevitch, T., Colussi, V., Wessels, B. W., Pillai, K., Maciunas, R. J., & Einstein, D. B. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.980 · Cited by 324
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Bahary, J.-P., Kline, R., Wharam, M., Schultz, C., Davey, P., Loeffler, J., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02106-x · Cited by 278
Variables associated with the development of complications from radiosurgery of intracranial tumors
Nedzi, L. A., Kooy, H., Alexander, E., Gelman, R. S., & Loeffler, J. S. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90675-t · Cited by 257
Rücker, G., Schwarzer, G., Carpenter, J., & Olkin, I. (2009) · Statistics in Medicine · doi:10.1002/sim.3511 · Cited by 252
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017
Nabors, L. B., Portnow, J., Ammirati, M., Baehring, J., Brem, H., Butowski, N., Fenstermaker, R. A., Forsyth, P., Hattangadi-Gluth, J., Holdhoff, M., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0166 · Cited by 231
Higuchi, Y., Serizawa, T., Nagano, O., Matsuda, S., Ono, J., Sato, M., Iwadate, Y., & Saeki, N. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.035 · Cited by 169
Should meta-analysts search Embase in addition to Medline?
Sampson, M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00110-0 · Cited by 160
Johnson, M. D., Avkshtol, V., Baschnagel, A. M., Meyer, K., Ye, H., Grills, I. S., Chen, P. Y., Maitz, A. H., Olson, R. E., Pieper, D. R., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.022 · Cited by 138
Searching one or two databases was insufficient for meta-analysis of observational studies
Lemeshow, A. R., Blum, R. E., Berlin, J. A., Stoto, M. A., & Colditz, G. A. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.03.004 · Cited by 137
Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications
Williams, B. J., Suki, D., Fox, B. D., Pelloski, C. E., Maldaun, M. V. C., Sawaya, R. A., Lang, F. F., & Rao, G. (2009) · Journal of neurosurgery · doi:10.3171/2008.11.jns08984 · Cited by 124
Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm
Angelov, L., Mohammadi, A. M., Bennett, E., Abbassy, M. A., Elson, P. J., Chao, S. T., Montgomery, J. S., Habboub, G., Vogelbaum, M. A., Suh, J. H., et al. (2017) · Journal of neurosurgery · doi:10.3171/2017.3.jns162532 · Cited by 117
Self-citationMurai, T., Ogino, H., Manabe, Y., Iwabuchi, M., Okumura, T., Matsushita, Y., Tsuji, Y., Suzuki, H., & Shibamoto, Y. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.11.027 · Cited by 74
Postoperative Stereotactic Radiosurgery to the Resection Cavity for Large Brain Metastases
Ling, D. C., Vargo, J. A., Wegner, R. E., Flíckinger, J. C., Burton, S. A., Engh, J. A., Amankulor, N., Quinn, A. E., Ozhasoglu, C., & Heron, D. E. (2014) · Neurosurgery · doi:10.1227/neu.0000000000000584 · Cited by 64
Multisession gamma knife surgery for large brain metastases
Hasegawa, T., Kato, T., Yamamoto, T., Iizuka, H., Nishikawa, T., Ito, H., & Kato, N. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2317-4 · Cited by 44
Cited by
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Vogelbaum, M. A., Brown, P. D., Messersmith, H., Brastianos, P. K., Burri, S., Cahill, D., Dunn, I. F., Gaspar, L. E., Gatson, N. T. N., Gondi, V., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02314 · Cited by 832
Self-citationLe Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx221 · Cited by 637
Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.016 · Cited by 592
Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain
Milano, M. T., Grimm, J., Niemierko, A., Soltys, S. G., Moiseenko, V., Redmond, K. J., Yorke, E., Sahgal, A., Xue, J., Mahadevan, A., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.013 · Cited by 402
Self-citationRadiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline
Gondi, V., Bauman, G., Bradfield, L., Burri, S. H., Cabrera, A. R., Cunningham, D. A., Eaton, B. R., Hattangadi‐Gluth, J. A., Kim, M. M., Kotecha, R., et al. (2022) · Practical Radiation Oncology · doi:10.1016/j.prro.2022.02.003 · Cited by 395
Self-citation
Metadata
- Authors
- Lehrer, E. J., Peterson, J. L., Zaorsky, N. G., Brown, P. D., Sahgal, A., Chiang, V. L., Chao, S. T., Sheehan, J. P., & Trifiletti, D. M.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 103
- Issue
- 3
- Pages
- 618-630
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2899172402
- Cited by
- 263
- References
- 41
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.